Evaluation of a point-of-care immunoassay test kit `StrongStep' for cryptococcal antigen detection
| dc.contributor.author | Mpoza, Edward | |
| dc.contributor.author | Mukaremera, Liliane | |
| dc.contributor.author | Akampurira, Andrew | |
| dc.contributor.author | Mahsa, Abassi | |
| dc.date.accessioned | 2025-04-14T09:05:19Z | |
| dc.date.available | 2025-04-14T09:05:19Z | |
| dc.date.issued | 2018-01-05 | |
| dc.description.abstract | HIV-associated cryptococcal meningitis is the leading cause of adult meningitis in Sub-Saharan Africa, accounting for 15%–20% of AIDS-attributable mortality. The development of point-of-care assays has greatly improved the screening and diagnosis of cryptococcal disease. We evaluated a point-of-care immunoassay, StrongStep (Liming Bio, Nanjing, Jiangsu, China) lateral flow assay (LFA), for cryptococcal antigen (CrAg) detection in cerebrospinal fluid (CSF) and plasma. | |
| dc.identifier.citation | Mpoza, E., Mukaremera, L., Kundura, D. A., Akampurira, A., Luggya, T., Tadeo, K. K., ... & Abassi, M. (2018). Evaluation of a point-of-care immunoassay test kit ‘StrongStep’for cryptococcal antigen detection. PLoS One, 13(1), e0190652. | |
| dc.identifier.other | https://doi.org/10.1371/journal.pone.0190652 | |
| dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/10618 | |
| dc.language.iso | en | |
| dc.publisher | PLoS One | |
| dc.title | Evaluation of a point-of-care immunoassay test kit `StrongStep' for cryptococcal antigen detection | |
| dc.type | Article |